Igor A. Strokov

Moscow, MOW, Russian Federation

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Algorithm for the diagnosis and treatment of patients with diabetic polyneuropathy. Expert Council Resolution (March 1, 2025)

Algorithm for the diagnosis and treatment of patients with diabetic polyneuropathy. Expert Council Resolution (March 1, 2025)

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Published: August 29, 2025

5q spinal muscular atrophy in adults

5q spinal muscular atrophy in adults

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Published: April 08, 2025

A diagnostic algorithm for tunnel mononeuropathies management (consensus of experts)

A diagnostic algorithm for tunnel mononeuropathies management (consensus of experts)

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Published: July 29, 2024

Role and place of ipidacrine in the therapy of diseases of the peripheral nervous system. The resolution of the expert council

Role and place of ipidacrine in the therapy of diseases of the peripheral nervous system. The resolution of the expert council

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Published: March 11, 2024

Efficacy and safety of Cytoflavin in the treatment of diabetic polyneuropathy: results of a multicenter, double-blind, placebo-controlled, randomized CYLINDER study

Efficacy and safety of Cytoflavin in the treatment of diabetic polyneuropathy: results of a multicenter, double-blind, placebo-controlled, randomized CYLINDER study

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Published: June 14, 2023

Efficacy and safety of the combined metabolic medication, containing inosine, nicotinamide, riboflavin and succinic acid, for the treatment of diabetic neuropathy: a multicenter randomized, double-blind, placebo-controlled parallel group clinical trial (CYLINDER).

Efficacy and safety of the combined metabolic medication, containing inosine, nicotinamide, riboflavin and succinic acid, for the treatment of diabetic neuropathy: a multicenter randomized, double-blind, placebo-controlled parallel group clinical trial (CYLINDER).

Journal: BMJ open diabetes research & care

Published: January 24, 2022

Early diagnosis of diabetic polyneuropathy based on the results of corneal nerve fibers examination

Early diagnosis of diabetic polyneuropathy based on the results of corneal nerve fibers examination

Journal: Vestnik oftalmologii

Published: October 16, 2020

'Point of no return' in diabetic neuropathies: a dangerous delusion

'Point of no return' in diabetic neuropathies: a dangerous delusion

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Published: October 19, 2019

Segawa's syndrome

Segawa's syndrome

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Published: June 04, 2019

Diabetic and non-diabetic neuropathies in patients with diabetes mellitus

Diabetic and non-diabetic neuropathies in patients with diabetes mellitus

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Published: June 05, 2018

α-Lipoic acid as the main pharmacological drug for in- and outpatient treatment of diabetic polyneuropathy

α-Lipoic acid as the main pharmacological drug for in- and outpatient treatment of diabetic polyneuropathy

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Published: April 12, 2017

Predictors of response to treatment with actovegin for 6 months in patients with type 2 diabetes and symptomatic polyneuropathy.

Predictors of response to treatment with actovegin for 6 months in patients with type 2 diabetes and symptomatic polyneuropathy.

Journal: Journal of diabetes and its complications

Published: September 07, 2016

Showing 1-12 of 16

Last Updated: 09/26/2026